|
|
|
2010³â04¿ù08ÀÏ 00½Ã00ºÐ |
|
|
|
|
¹Ì±¹½Å°æÇÐȸ, ¸ÓÅ© ¼¼·Î³ë ´Ù¹ß¼º°æÈÁõ Ä¡·áÁ¦ ÀÚ·á ¹ßÇ¥ 10ÀϺÎÅÍ 17ÀÏ Ä³³ª´Ù Åä·ÐÅä¿¡¼ °³ÃÖ |
|
¸ÓÅ© ¼¼·Î³ë ÀǾà»ç¾÷ºÎ´Â ¿À´Â 4¿ù 10ÀÏ - 17ÀÏ Ä³³ª´Ù Åä·ÐÅä¿¡¼ °³ÃֵǴ Á¦ 62Â÷ ¹Ì±¹½Å°æÇÐȸ(AAN; American Academy of Neurology) ¿¬·Ê ÇмúȸÀÇ¿¡¼ ´Ù¹ß¼º°æÈÁõ Ä¡·á¿ë ½ÂÀÎ¾à ¹× ÀÓ»ó½ÃÇè¾à Æ÷Æ®Æú¸®¿À¿¡ ´ëÇÑ »õ·Î¿î ÀڷḦ ¹ßÇ¥ÇÒ °èȹÀÌ´Ù. À̹ø¿¡ ¹ßÇ¥µÉ ÀÚ·á´Â Àç¹ßÇü ´Ù¹ß¼º°æÈÁõ¿¡ ´ëÇØ ±â½ÂÀÎµÈ Ä¡·áÁ¦ ·¹ºñÇÁ(Rebif ÀÎÅÍÆä·Ð º£Å¸-1a)¿Í ÇöÀç ¿©·¯ ±¹°¡¿¡¼ ½É»ç°¡ ÁøÇàÁßÀÎ Àç¹ßÇü ´Ù¹ß¼º°æÈÁõ °æ±¸¿ë ½Å¾à Ŭ¶óµå¸®ºóÁ¤(Cladribine Tablets)¿¡ ´ëÇØ ÁßÁ¡ÀûÀ¸·Î ´Ù·ê ¿¹Á¤ÀÌ´Ù.
¸ÓÅ© ¼¼·Î³ë ¿¬±¸°³¹ß ÃÑÃ¥ÀÓÀÚ(Head of Global Research and Development) º£¸¥Çϵå Ä¿½¬¹Ù¿ò(Bernhard Kirschbaum)Àº “¿ì¸®´Â ÀÌ ºÐ¾ßÀÇ ¼±µÎ±â¾÷À¸·Î¼ ´Ù¹ß¼º°æÈÁõ Ä¡·á ¹× ±× ±Ù°£ÀÌ µÇ´Â °úÇÐÀÇ ¼±Áøȸ¦ ÀÌ·ç±â À§ÇÑ ±»Àº ÀÇÁö¸¦ °®°í ÀÖ´Ù”¸ç, “À̹ø ¹Ì±¹½Å°æÇÐȸ ¹ßÇ¥ ÀÚ·á´Â ·¹ºñÇÁ� ¹× Ŭ¶óµå¸®ºóÁ¤¿¡ ´ëÇÑ ±âÁ¸ Áö½ÄÀ» ³ÐÈ÷°í ÀÌ Áúº´¿¡ ´ëÇÑ ÀÌÇظ¦ ´õ¿í ³ôÀ̴µ¥ ±â¿©ÇÒ °Í”À̶ó°í ¸»Çß´Ù.
|
|
|
|
|
|